Did Drug Use Trigger Schizophrenia? A Study of 232 First Episodes | Research

The takeaway

In a population-based study of 232 first-episode schizophrenia cases, people with schizophrenia were twice as likely to have a history of substance abuse, with 88% of drug abusers using cannabis, and drug abuse often began before the first signs of illness.

Read this if you want to understand the relationship between cannabis use and schizophrenia onset.

88% of drug-abusing first-episode schizophrenia patients used cannabis

What the researchers found

People experiencing their first episode of schizophrenia were twice as likely as controls to have a lifetime history of substance abuse (alcohol abuse: 23.7% vs 12.3%; drug abuse: 14.2% vs 7.0%). Among patients who abused drugs, 88% used cannabis. Sixty-two percent of patients with drug abuse began using before the first sign of their disorder.

A striking finding was that drug abuse onset and illness onset occurred within the same month in 34.6% of cases, suggesting a temporal connection. However, no temporal correlation was found between abuse onset and the onset of the first psychotic episode specifically. Over five years of follow-up, patients with early substance abuse showed more positive symptoms, less affective flattening, and worse outcomes in treatment compliance, rehabilitation, and employment.

Why it matters

This study addressed one of the most debated questions in psychiatry: whether cannabis and other substance use can trigger schizophrenia. The finding that drug abuse often preceded illness onset, and that onset timing frequently coincided, suggested a possible precipitating role. However, the researchers were careful to conclude that only a "small proportion" of schizophrenias might have been precipitated by substance abuse.

The numbers in context

Alcohol abuse: 23.7% in schizophrenia vs 12.3% in controls. Drug abuse: 14.2% vs 7.0%. Cannabis was used by 88% of drug abusers. Drug abuse preceded illness onset in 62% of cases. Drug abuse and illness onset coincided within the same month in 34.6% of cases.

How the study worked

This was a population-based study using both retrospective and prospective designs. The retrospective component assessed 232 first-episode schizophrenia cases using the IRAOS interview compared with controls. The prospective component followed a subsample of 115 patients over five years with six cross-sectional assessments from first admission.

What this study cannot tell us

The retrospective component relied on patient recall, which may be unreliable especially regarding the timing of first symptoms. The correlation between drug use onset and illness onset does not prove causation. Some patients may have been self-medicating early prodromal symptoms with drugs. The study could not definitively separate substance-precipitated psychosis from psychosis with comorbid substance use.

How to read the evidence

This is a population-based cohort study with both retrospective and prospective components and a five-year follow-up, providing moderate-level evidence.

When this study was published

Published in 2002. The cannabis-psychosis relationship has been extensively studied since, with larger cohort studies and meta-analyses.

The bigger picture

This study contributed to the growing evidence base linking cannabis use to schizophrenia risk, particularly regarding timing. The finding that substance abuse worsened five-year outcomes has been consistently replicated and has influenced dual-diagnosis treatment approaches that address both substance use and psychotic disorders together.

Questions still open

Were the patients who used cannabis before illness onset self-medicating prodromal symptoms they could not yet identify? Would the outcomes have differed if substance abuse had been treated concurrently with schizophrenia from the first episode?

Common questions

Does cannabis cause schizophrenia?

This study found that cannabis use often preceded schizophrenia onset, but the researchers cautiously concluded that only a "small proportion" of cases might have been precipitated by substance use. The relationship is complex and likely involves genetic vulnerability interacting with cannabis exposure.

Why did substance-abusing patients have worse outcomes?

Over five years, patients with early substance abuse had poorer treatment compliance, used fewer rehabilitation services, and had lower employment rates. They also showed different symptom patterns, with more positive symptoms and less emotional flattening.

Read the original research

Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes.

Schizophrenia research, 54(3), 243-51

View on PubMed ↗

Citation

Bühler, Babette; Hambrecht, Martin; Löffler, Walter; an der Heiden, Wolfram; Häfner, Heinz. (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes.. Schizophrenia research, 54(3), 243-51.